Medtronic
 
 

Insertable
Cardiac Monitor

Clinical Studies and Guidelines

There is a strong and growing body of clinical evidence highlighting the importance of detecting cardiac abnormalities in patients with syncope or unexplained symptoms.

Studies have demonstrated the clinical and economic value of using an insertable cardiac monitor (ICM), such as Reveal®, in the diagnosis of unexplained syncope:

The Risk of Cardiac Syncope
New England Journal of Medicine
Cost Effectiveness of Reveal vs. Conventional Testing
Journal of the American College of Cardiologists

General Guidelines

AHA/ACCF and ESC Guidelines*1,2 support the use of an insertable cardiac monitor to assess symptoms possibly related to rhythm disturbances is indicated for:

(1) patients with clinical syndromes or situations at increased risk of cardiac arrhythmias

and/or

(2) patients who experience transient symptoms such as dizziness, palpitation, syncope and chest pain, that may suggest a cardiac arrhythmia.

For more information on the guidelines refer to:

*AHA/ACCF—American Heart Association/American College of Cardiology Foundation ESC—European Society of Cardiology

1Strickberger SA, Benson DW, Biaggioni I, et al. AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils and the American College of Cardiology Foundation: In collaboration with the Heart Rhythm Society. Circulation. January 17, 2006;113(2):316-327. 2Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope—update 2004. Europace. November 2004;6(6):467-537.

 

Additional Information